| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Vaxcyte Inc (NASDAQ: PCVX)
PCVX Technical Analysis
5
| As on 9th Jun 2023 PCVX STOCK Price closed @ 50.56 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 25.28 & Strong Buy for SHORT-TERM with Stoploss of 21.21 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PCVXSTOCK Price
| Open | 50.91 | Change | Price | % |
| High | 51.35 | 1 Day | -0.40 | -0.78 |
| Low | 50.05 | 1 Week | 1.59 | 3.25 |
| Close | 50.56 | 1 Month | 7.15 | 16.47 |
| Volume | 323000 | 1 Year | 28.40 | 128.16 |
| 52 Week High 53.31 | 52 Week Low 17.46 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PCVX Daily Charts |
PCVX Intraday Charts |
Whats New @ Bazaartrend |
PCVX Free Analysis |
|
|
PCVX Important Levels Intraday
| RESISTANCE | 53.07 |
| RESISTANCE | 52.26 |
| RESISTANCE | 51.77 |
| RESISTANCE | 51.27 |
| SUPPORT | 49.85 |
| SUPPORT | 49.35 |
| SUPPORT | 48.86 |
| SUPPORT | 48.05 |
PCVX Forecast May 2024
| 4th UP Forecast | 67.77 |
| 3rd UP Forecast | 62.25 |
| 2nd UP Forecast | 58.84 |
| 1st UP Forecast | 55.43 |
| 1st DOWN Forecast | 45.69 |
| 2nd DOWN Forecast | 42.28 |
| 3rd DOWN Forecast | 38.87 |
| 4th DOWN Forecast | 33.35 |
PCVX Weekly Forecast
| 4th UP Forecast | 57.13 |
| 3rd UP Forecast | 55.02 |
| 2nd UP Forecast | 53.72 |
| 1st UP Forecast | 52.42 |
| 1st DOWN Forecast | 48.70 |
| 2nd DOWN Forecast | 47.40 |
| 3rd DOWN Forecast | 46.10 |
| 4th DOWN Forecast | 43.99 |
PCVX Forecast2024
| 4th UP Forecast | 123.9 |
| 3rd UP Forecast | 100.38 |
| 2nd UP Forecast | 85.84 |
| 1st UP Forecast | 71.3 |
| 1st DOWN Forecast | 29.82 |
| 2nd DOWN Forecast | 15.28 |
| 3rd DOWN Forecast | 0.74 |
| 4th DOWN Forecast | -22.78 |
Vaxcyte Inc ( NASDAQ USA Symbol : PCVX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PCVX Business Profile
Vaxcyte, Inc., a preclinical-stage biotechnology vaccine company, develops novel vaccines to prevent or treat infectious diseases worldwide. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting Porphyromonas gingivalis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in Foster City, California. Address: 353 Hatch Drive, Foster City, CA, United States, 94404
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service